Amphastar Pharmaceuticals Inc (NAS:AMPH)
$ 41.3 -1.07 (-2.53%) Market Cap: 2.02 Bil Enterprise Value: 2.41 Bil PE Ratio: 14.29 PB Ratio: 3.00 GF Score: 77/100

Q3 2022 Amphastar Pharmaceuticals Inc Earnings Call Transcript

Nov 07, 2022 / 10:00PM GMT
Release Date Price: $30.1 (+1.14%)
Operator

Greetings, and welcome to the Amphastar Pharmaceuticals, Inc. Third Quarter Earnings Call. (Operator Instructions)

Please note that certain statements made during this call regarding matters that are not historical facts, including, but not limited to, management's outlook or predictions for future periods, are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled Forward-Looking Statements in the press release issued today and the presentation on the company's website. Also, please refer to our SEC filings, which can be found on our website and the SEC website, for a discussion of numerous factors that may impact our future performance.

We will also discuss certain non-GAAP measures. Important information on the use of these measures and reconciliations to U.S. GAAP may be found in our earnings release. Please note that this conference call is being recorded.

Our speakers today are Mr. Bill Peters, CFO; Mr. Dan Dischner, Vice President of Corporate Communications; and Mr. Tony

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot